In Liz Canner's documentary "Orgasm, Inc.," officials from one drug company admit that they were drawn heavily into the hunt for a female orgasm pill because of an incorrect press report that suggested they already had one.
Their stock price, on the strength of one small false rumor, went stratospheric.
The market is famously unsentimental about things like this. The stock went up because brokers and investors believed that a pill like that would be incredibly popular.
And so, even though today we're going to talk about companies and clinicians cynically pursuing the fast buck of a female dysfunction cure, I want to acknowledge that, at one end of the pipeline, the problem is us and our modern insistence that there should be a pill or a patch that fixes everything, even something as nuanced and compicated as female orgasm.